Biotricity Debt to Equity Ratio 2015-2025 | BTCY
Current and historical debt to equity ratio values for Biotricity (BTCY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Biotricity debt/equity for the three months ending March 31, 2025 was 0.00.
| Biotricity Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.04B | $-0.03B | -1.18 |
| 2024-12-31 | $0.04B | $-0.03B | -1.19 |
| 2024-09-30 | $0.04B | $-0.03B | -1.17 |
| 2024-06-30 | $0.04B | $-0.03B | -1.18 |
| 2024-03-31 | $0.04B | $-0.03B | -1.19 |
| 2023-12-31 | $0.03B | $-0.03B | -1.20 |
| 2023-09-30 | $0.03B | $-0.03B | -1.26 |
| 2023-06-30 | $0.03B | $-0.02B | -1.26 |
| 2023-03-31 | $0.03B | $-0.02B | -1.33 |
| 2022-12-31 | $0.02B | $-0.02B | -1.43 |
| 2022-09-30 | $0.02B | $-0.01B | -1.76 |
| 2022-06-30 | $0.02B | $-0.01B | -2.85 |
| 2022-03-31 | $0.02B | $0.00B | -8.78 |
| 2021-12-31 | $0.02B | $0.00B | 8.08 |
| 2021-09-30 | $0.01B | $0.01B | 0.80 |
| 2021-06-30 | $0.01B | $-0.01B | -1.26 |
| 2021-03-31 | $0.01B | $-0.01B | -1.65 |
| 2020-12-31 | $0.02B | $-0.01B | -1.48 |
| 2020-09-30 | $0.01B | $-0.01B | -1.28 |
| 2020-06-30 | $0.01B | $-0.01B | -1.28 |
| 2020-03-31 | $0.01B | $0.00B | -1.67 |
| 2019-12-31 | $0.01B | $0.00B | -3.89 |
| 2019-09-30 | $0.01B | $-0.01B | -1.22 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-03-31 | $0.00B | $0.00B | -1.28 |
| 2018-12-31 | $0.00B | $0.00B | 0.00 |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | $0.00B | 4.36 |
| 2017-12-31 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.01B | $0.00B | -1.11 |
| 2016-12-31 | $0.00B | $0.00B | -1.02 |
| 2015-12-31 | $0.00B | $0.00B | -1.42 |
| 2015-09-30 | $0.00B | $0.00B | -1.07 |
| 2014-09-30 | $0.00B | $0.00B | -1.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.011B | $0.014B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.350B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.22 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.155B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |